(0.31%) 5 115.66 points
(0.32%) 38 361 points
(0.33%) 15 981 points
(-0.94%) $83.06
(5.51%) $2.03
(0.36%) $2 355.60
(0.41%) $27.65
(4.00%) $959.00
(-0.23%) $0.933
(-0.39%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
@ $0.190
発行日: 7 2月 2024 @ 01:13
リターン: -12.05%
Live Chart Being Loaded With Signals
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally...
Stats | |
---|---|
本日の出来高 | 162 680 |
平均出来高 | 496 482 |
時価総額 | 3.92M |
EPS | $-0.110 ( 2024-04-15 ) |
次の収益日 | ( $-0.160 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0900 |
ATR14 | $0.00200 (1.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Schneid Yair | Sell | 0 | Common Stock |
2023-08-04 | Stankovich Thomas | Sell | 108 | Common Stock, $0.001 par value per share |
2023-08-24 | Stankovich Thomas | Sell | 39 | Common Stock, $0.001 par value per share |
2023-09-01 | Stankovich Thomas | Sell | 118 | Common Stock, $0.001 par value per share |
2023-10-11 | Stankovich Thomas | Sell | 39 | Common Stock, $0.001 par value per share |
INSIDER POWER |
---|
-2.87 |
Last 95 transactions |
Buy: 10 386 223 | Sell: 2 711 639 |
ボリューム 相関
ReShape Lifesciences Inc 相関
10 最も負の相関 | |
---|---|
NETE | -0.922 |
AMRB | -0.906 |
RAVN | -0.893 |
BOCH | -0.882 |
LSCC | -0.88 |
LSTR | -0.876 |
MMAC | -0.872 |
PDFS | -0.868 |
USLM | -0.864 |
RNLC | -0.863 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
ReShape Lifesciences Inc 相関 - 通貨/商品
ReShape Lifesciences Inc 財務諸表
Annual | 2023 |
収益: | $8.68M |
総利益: | $5.55M (63.93 %) |
EPS: | $-1.910 |
FY | 2023 |
収益: | $8.68M |
総利益: | $5.55M (63.93 %) |
EPS: | $-1.910 |
FY | 2022 |
収益: | $11.24M |
総利益: | $6.80M (60.52 %) |
EPS: | $-108.90 |
FY | 2021 |
収益: | $13.60M |
総利益: | $8.35M (61.38 %) |
EPS: | $-250.16 |
Financial Reports:
No articles found.
ReShape Lifesciences Inc
ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。